1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow ORC-13661: new trials by email Literature Review of ORC-13661 trials Research Report on ORC-13661
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin ORC-13661, Placebo - Ototoxicity, Drug-Induced | Phase 2 | Recruiting | Kevin Winthrop | 105 | 2025-06-02 | 2026-10-01 |
Hearing Loss (1) · Ototoxicity (1)
Kevin Winthrop (1)
United States (1)
Edwin Rubel, PhD (1) · Kevin L Winthrop, MD, MPH (1)
U01DC020175 (1)